EcoDrugPlus

Cholinergic Receptor Nicotinic Alpha 4 Subunit

Ensembl ID : ENSCLAG00000002115
Gene Symbol: CHRNA4
3 Cross references
206 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 7 Subunit

Ensembl ID : ENSCLAG00000010378
Gene Symbol: CHRNA7
3 Cross references
249 Possible Orthologues:

Cholinergic Receptor Nicotinic Beta 2 Subunit

Ensembl ID : ENSCLAG00000005132
Gene Symbol: CHRNB2
3 Cross references
198 Possible Orthologues:

Cholinergic Receptor Nicotinic Beta 4 Subunit

Ensembl ID : ENSCLAG00000005558
Gene Symbol: CHRNB4
2 Cross references
199 Possible Orthologues:

Chymase

Ensembl ID : ENSCLAG00000014113
Gene Symbol: LOC102024194
2 Cross references
315 Possible Orthologues:

Chymase-Like

Ensembl ID : ENSCLAG00000000549
Gene Symbol: LOC102014853
1 Cross references
315 Possible Orthologues:

Coagulation Factor Ii, Thrombin

Ensembl ID : ENSCLAG00000015618
Gene Symbol: F2
2 Cross references
86 Possible Orthologues:

Coagulation Factor Iii, Tissue Factor

Ensembl ID : ENSCLAG00000006707
Gene Symbol: F3
2 Cross references
246 Possible Orthologues:

Coagulation Factor Vii

Ensembl ID : ENSCLAG00000004276
Gene Symbol: F7
2 Cross references
203 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSCLAG00000004028
Gene Symbol: F10
3 Cross references
239 Possible Orthologues:

Coagulation Factor Xi

Ensembl ID : ENSCLAG00000012318
Gene Symbol: F11
2 Cross references
215 Possible Orthologues:

Coagulation Factor Xii

Ensembl ID : ENSCLAG00000016792
Gene Symbol: F12
2 Cross references
187 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).